Tmo stock price forecast current "TMO stock price forecast"

Current "TMO stock price forecast" models factor in anticipated Q3 revenue gains from lab equipment sales, reflecting increased R&D spending across pharmaceutical sectors. This underpins potential upside momentum amid sector-wide resilience. At first glance, Thermo Fisher Scientific seems to have a decent ROE. Further, the company's ROE is similar to the industry average of 13%. This certainly adds some context to Thermo Fisher Scientific's exceptional 20% net income growth seen over the past five years. We believe that there might also be other aspects that are positively influencing the company's earnings growth. For instance, the company has a low payout ratio or is being managed efficiently. Among the 25 analysts covering TMO stock, the consensus is a “Strong Buy.” That’s based on 18 “Strong Buy” ratings, three “Moderate Buys,” and four “Holds.” In the latest "TMO stock price forecast", macroeconomic headwinds such as interest rate changes might cap near-term upside, but recurring revenue streams from consumables are expected to mitigate downside risk considerably.